The Present and FutureJACC State-of-the-Art ReviewCardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Madhavan has received support from an institutional grant by the National Institutes of Health/National Heart, Lung, and Blood Institute to Columbia University Irving Medical Center (T32 HL007854). Dr. Bikdeli has served as a consulting expert, on behalf of the plaintiff, for litigation related to a specific type of inferior vena cava filters. Dr. Brodie has received research support from ALung Technologies; and has served on the Medical Advisory Boards of ALung Technologies, Baxter, BREETHE, Xenios, and Hemovent. Dr. Kirtane has received support from institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, Philips, and ReCor Medical. Dr. Stone has received speaking or other honoraria from Cook, Terumo, Qool Therapeutics, and Orchestra Biomed; has served as a consultant to Valfix, TherOx, Vascular Dynamics, Robocath, HeartFlow, Gore, Ablative Solutions, Miracor, Neovasc, V-Wave, Abiomed, Ancora, MAIA Pharmaceuticals, Vectorious, Reva, and Matrizyme; and has received equity/options from Ancora, Qool Therapeutics, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, MedFocus family of funds, and Valfix. Dr. Krumholz has worked under contract with the Centers for Medicare and Medicaid Services to support quality measurement programs; has received a research grant, through Yale, from Medtronic and the U.S. Food and Drug Administration to develop methods for post-market surveillance of medical devices; has received research grants from Medtronic; and has received a research grant from Johnson & Johnson, through Yale University, to support clinical trial data sharing; has received a research agreement, through Yale University, from the Shenzhen Center for Health Information for work to advance intelligent disease prevention and health promotion; has collaborated with the National Center for Cardiovascular Diseases in Beijing; has received payment from the Arnold & Porter Law Firm for work related to the Sanofi clopidogrel litigation; has received payment from the Ben C. Martin Law Firm for work related to the Cook CELECT inferior vena cava filter litigation; has received payment from the Siegfried and Jensen Law Firm for work related to Vioxx litigation; has chaired the Cardiac Scientific Advisory Board for UnitedHealth; was a participant/participant representative of the IBM Watson Health Life Sciences Board; has served on the Advisory Boards of Element Science and Facebook; has served on the Physician Advisory Board for Aetna; and cofounded HugoHealth, a personal health information platform, and Refactor Health, an enterprise health care artificial intelligence–augmented data enterprise. Dr. Parikh has received institutional grants/research support from Abbott Vascular, Shockwave Medical, TriReme Medical, Sumodics, Silk Road Medical, and the National Institutes of Health; has received consulting fees from Terumo and Abiomed; and has served on the Advisory Boards of Abbott, Medtronic, Boston Scientific, CSI, and Philips. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.
- ∗
Drs. Driggin and Madhavan contributed equally to this work.